Phase II Clinical Development of New Drugs
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful exec...
Κύριοι συγγραφείς: | Ting, Naitee (Συγγραφέας), Chen, Ding-Geng (Συγγραφέας), Ho, Shuyen (Συγγραφέας), Cappelleri, Joseph C. (Συγγραφέας) |
---|---|
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Singapore :
Springer Singapore : Imprint: Springer,
2017.
|
Σειρά: | ICSA Book Series in Statistics,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R Order-Restricted Analysis of Microarray Data /
Έκδοση: (2012) -
Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
ανά: Wassmer, Gernot, κ.ά.
Έκδοση: (2016) -
Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry
ανά: Burdick, Richard K., κ.ά.
Έκδοση: (2017) -
Quantitative Decisions in Drug Development
ανά: Chuang-Stein, Christy, κ.ά.
Έκδοση: (2017) -
New Drug Development An Introduction to Clinical Trials: Second Edition /
ανά: Turner, J. Rick
Έκδοση: (2010)